Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 

Slides:



Advertisements
Similar presentations
Jihye Choi June. Introduction Hepatitis B virus -Four overlapping reading frames -S: the viral surface proteins -P: viral polymerase.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 58, Issue 1, Pages (January 2013)
Volume 50, Issue 4, Pages (April 2009)
Hepatic CD141+IFNλ+ DC subset: One against all?
Volume 117, Issue 1, Pages (July 1999)
Volume 152, Issue 5, Pages (April 2017)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Reactive oxygen species in the normal and acutely injured liver
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Volume 52, Issue 3, Pages (March 2010)
Lymphotoxins: New Targets for Hepatocellular Carcinoma
NS5A inhibitors in the treatment of hepatitis C
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Hepatitis C-associated B-cell non-Hodgkin lymphomas
Alcohol and toxicity Journal of Hepatology
Immigration and viral hepatitis
Is Hepatitis C Virus Carcinogenic?
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Hepatitis B and C virus-related carcinogenesis
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Mechanisms of HBV-related hepatocarcinogenesis
Volume 69, Issue 2, Pages (August 2018)
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma  André Lechel, Michael P. Manns, K.Lenhard Rudolph 
How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?  Neil Rajoriya,
Volume 61, Issue 2, Pages (August 2014)
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.
Targeting gut flora to prevent progression of hepatocellular carcinoma
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Why men are at higher risk for hepatocellular carcinoma?
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Hepatitis B and C virus-related carcinogenesis
Volume 50, Issue 4, Pages (April 2009)
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Volume 61, Issue 1, Pages S79-S90 (November 2014)
miR-122 – A key factor and therapeutic target in liver disease
Chetana Lim, Chady Salloum, Daniel Azoulay
Immigration and viral hepatitis
HCV targeting of patients with cirrhosis
Volume 60, Issue 5, Pages (May 2014)
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
Chronic hepatitis B in children and adolescents
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
HCV animal models and liver disease
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Eric Robinet, Thomas F. Baumert  Journal of Hepatology 
Genetics of hepatocellular carcinoma: The next generation
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Genetic profiling of hepatocellular carcinoma using next-generation sequencing  Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva  Journal of Hepatology  Volume 65, Issue 5, Pages 1031-1042 (November 2016) DOI: 10.1016/j.jhep.2016.05.035 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Mutational landscape of HCC. Graphical summary of the main mutated genes in HCC and their reported frequency. Note that some mutations may co-exist in the same patient. Data suggest that background etiology impact mutation rate. Most mutations affect 3 genes, TERT promoter, CTNNB1 and TP53. Journal of Hepatology 2016 65, 1031-1042DOI: (10.1016/j.jhep.2016.05.035) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Viral mechanisms of liver carcinogenesis. Direct and indirect mechanisms of viral related liver carcinogenesis are represented. Indirect mechanisms are related to the development of cirrhosis triggered by chronic inflammation and oxidative stress induced by chronic viral hepatitis. In vitro studies and mouse model have suggested that HCV proteins could have oncogenic properties even if the relevance in humans remains debated. The direct oncogenic mechanisms are mainly due to action of viral oncoproteins (Hbx in HBV), chromosomal instability induced by HBV integration and insertional mutagenesis (HBV and AAV2) with aberrant regulation of gene expression or induction of fusion protein between human DNA and HBV. The genes targeted by clonal viral integrations are represented in the blue box; some of them are targeted by both HBV and AAV2. Journal of Hepatology 2016 65, 1031-1042DOI: (10.1016/j.jhep.2016.05.035) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions